174 related articles for article (PubMed ID: 30194213)
1. Portal Vein Embolization (PVE)
Treska V; Fichtl J; Ludvik J; Bruha J; Liska V; Treskova I; Kucera R; Topolcan O; Lysak D; Skalicky T; Ferda J
Anticancer Res; 2018 Sep; 38(9):5531-5537. PubMed ID: 30194213
[TBL] [Abstract][Full Text] [Related]
2. Portal vein embolisation with application of haematopoietic stem cells in patients with primarily or non-resectable colorectal liver metastases.
Treska V; Liska V; Fichtl J; Lysak D; Mirka H; Bruha J; Duras P; Treskova I; Nahlik J; Simanek V; Topolcan O
Anticancer Res; 2014 Dec; 34(12):7279-85. PubMed ID: 25503161
[TBL] [Abstract][Full Text] [Related]
3. Growth of colorectal liver metastases is not accelerated by intraportal administration of stem cells after portal vein embolization.
Brůha J; Treska V; Mírka H; Hosek P; Fichtl J; Skalický T; Bajcurová K; Ludvík J; Duras P; Lysák D; Liska V
Rozhl Chir; 2019; 98(4):159-166. PubMed ID: 31159549
[TBL] [Abstract][Full Text] [Related]
4. Portal Vein Embolization with Contralateral Application of Stem Cells Facilitates Increase of Future Liver Remnant Volume in Patients with Liver Metastases.
Ludvík J; Duras P; Třeška V; Matoušková T; Brůha J; Fichtl J; Lysák D; Ferda J; Baxa J
Cardiovasc Intervent Radiol; 2017 May; 40(5):690-696. PubMed ID: 28091729
[TBL] [Abstract][Full Text] [Related]
5. Predictive Value of Growth Factors and Interleukins for Future Liver Remnant Volume and Colorectal Liver Metastasis Volume Growth Following Portal Vein Embolization and Autologous Stem Cell Application.
Fichtl J; Treska V; Lysak D; Mirka H; Duras P; Karlikova M; Skalicky T; Vodička J; Topolcan O
Anticancer Res; 2016 Apr; 36(4):1901-7. PubMed ID: 27069178
[TBL] [Abstract][Full Text] [Related]
6. Methods to Increase Future Liver Remnant Volume in Patients with Primarily Unresectable Colorectal Liver Metastases: Current State and Future Perspectives.
Treska V
Anticancer Res; 2016 May; 36(5):2065-71. PubMed ID: 27127106
[TBL] [Abstract][Full Text] [Related]
7. Portal vein embolization does not affect the long-term survival and risk of cancer recurrence among colorectal liver metastases patients: A prospective cohort study.
Collin Y; Paré A; Belblidia A; Létourneau R; Plasse M; Dagenais M; Turcotte S; Martel G; Roy A; Lapointe R; Vandenbroucke-Menu F
Int J Surg; 2019 Jan; 61():42-47. PubMed ID: 30537548
[TBL] [Abstract][Full Text] [Related]
8. Portal vein embolization and autologous CD133+ bone marrow stem cells for liver regeneration: initial experience.
Fürst G; Schulte am Esch J; Poll LW; Hosch SB; Fritz LB; Klein M; Godehardt E; Krieg A; Wecker B; Stoldt V; Stockschläder M; Eisenberger CF; Mödder U; Knoefel WT
Radiology; 2007 Apr; 243(1):171-9. PubMed ID: 17312278
[TBL] [Abstract][Full Text] [Related]
9. Pros and Cons of Portal Vein Embolization With Hematopoietic Stem Cells Application in Colorectal Liver Metastases Surgery.
Treska V; Bruha J; Liska V; Fichtl J; Prochazkova K; Petrakova T; Hosek P
In Vivo; 2020; 34(5):2919-2925. PubMed ID: 32871833
[TBL] [Abstract][Full Text] [Related]
10. Portal vein embolization and application of autologous stem cells in patients with primary unresectable liver tumours.
Treska V; Koza V; Lysak D; Slauf F; Mirka H; Sutnar A; Skalicky T; Fichtl J; Ferda J
Bratisl Lek Listy; 2013; 114(7):389-93. PubMed ID: 23822623
[TBL] [Abstract][Full Text] [Related]
11. Portal vein ligation as an efficient method of increasing the future liver remnant volume in the surgical treatment of colorectal metastases.
Capussotti L; Muratore A; Baracchi F; Lelong B; Ferrero A; Regge D; Delpero JR
Arch Surg; 2008 Oct; 143(10):978-82; discussion 982. PubMed ID: 18936377
[TBL] [Abstract][Full Text] [Related]
12. Tumor progression after preoperative portal vein embolization.
Hoekstra LT; van Lienden KP; Doets A; Busch OR; Gouma DJ; van Gulik TM
Ann Surg; 2012 Nov; 256(5):812-7; discussion 817-8. PubMed ID: 23095626
[TBL] [Abstract][Full Text] [Related]
13. Impact of portal vein embolization on long-term survival of patients with primarily unresectable colorectal liver metastases.
Wicherts DA; de Haas RJ; Andreani P; Sotirov D; Salloum C; Castaing D; Adam R; Azoulay D
Br J Surg; 2010 Feb; 97(2):240-50. PubMed ID: 20087967
[TBL] [Abstract][Full Text] [Related]
14. [Experimental promotion of liver regeneration after portal vein branch ligation].
Liška V; Třeška V; Mírka H; Vyčítal O; Brůha J; Haidingerová L; Beneš J; Tonar Z; Pálek R; Rosendorf J
Rozhl Chir; 2018; 97(5):239-245. PubMed ID: 29792723
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous percutaneous right portal vein embolization and left liver tumor radiofrequency ablation prior to a major right hepatic resection for bilateral colorectal metastases.
Elias D; Santoro R; Ouellet JF; Osmak L; de Baere T; Roche A
Hepatogastroenterology; 2004; 51(60):1788-91. PubMed ID: 15532827
[TBL] [Abstract][Full Text] [Related]
16. In situ split plus portal vein ligation (ISLT) - a salvage procedure following inefficient portal vein embolization to gain adequate future liver remnant volume prior to extended liver resection.
Lehwald-Tywuschik N; Vaghiri S; Schulte Am Esch J; Alaghmand S; Klosterkemper Y; Schimmöller L; Lachenmayer A; Ashmawy H; Krieg A; Topp SA; Rehders A; Knoefel WT
BMC Surg; 2020 Apr; 20(1):63. PubMed ID: 32252737
[TBL] [Abstract][Full Text] [Related]
17. Impact of portal vein embolization on expression of cancer stem cell markers in regenerated liver and colorectal liver metastases.
Williamson JM; Thairu N; Katsoulas N; Stamp G; Ahmad R; du Potet E; Levicar N; Gordon M; Stebbing J; Habib NA; Jiao LR
Scand J Gastroenterol; 2010 Dec; 45(12):1472-9. PubMed ID: 20586536
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy after portal vein embolization to protect against tumor growth during liver hypertrophy before hepatectomy.
Fischer C; Melstrom LG; Arnaoutakis D; Jarnagin W; Brown K; D'Angelica M; Covey A; DeMatteo R; Allen P; Kingham TP; Tuorto S; Kemeny N; Fong Y
JAMA Surg; 2013 Dec; 148(12):1103-8. PubMed ID: 24173207
[TBL] [Abstract][Full Text] [Related]
19. Portal vein embolization stimulates tumour growth in patients with colorectal cancer liver metastases.
Simoneau E; Aljiffry M; Salman A; Abualhassan N; Cabrera T; Valenti D; El Baage A; Jamal M; Kavan P; Al-Abbad S; Chaudhury P; Hassanain M; Metrakos P
HPB (Oxford); 2012 Jul; 14(7):461-8. PubMed ID: 22672548
[TBL] [Abstract][Full Text] [Related]
20. Does portal vein embolization prior to liver resection influence the oncological outcomes - A propensity score matched comparison.
Huiskens J; Olthof PB; van der Stok EP; Bais T; van Lienden KP; Moelker A; Krumeich J; Roumen RM; Grünhagen DJ; Punt CJA; van Amerongen M; de Wilt JHW; Verhoef C; Van Gulik TM
Eur J Surg Oncol; 2018 Jan; 44(1):108-114. PubMed ID: 29126672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
